Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Jackery Launches E2000v2 - The Most Compact LFP 2kWh Backup Power Solar Generator to Ever Hit the Market
-
Kratos Completes Significant Milestone on Cost Optimized Limited-Life Turbofan Engine
-
Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)
-
Form 8.3 - Keywords Studios Plc
-
Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
-
Announces Payment of $3.0MM Final Match Payment Enabling Access to Remainder of $17.0MM CPRIT Grant
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Complete Solar is Winning Bidder in SunPower Chapter 11 Proceedings
-
Metavesco and Local Choice Spirits Announce Joint Venture to Launch Limited Edition Bourbon Series
-
Fengate releases inaugural firmwide Sustainability Report
-
Corza Medical Appoints Jason Abair as Vice President of Legal & Chief Compliance Officer
-
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
-
Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series
-
Corza Medical Appoints Jason Abair as Vice President of Legal & Chief Compliance Officer
-
Form 8.3 - AXA INVESTMENT MANAGERS: Segro plc
-
Celldex Announces Upcoming Late Breaking Oral Presentation of 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV Congress 2024
-
ERES REIT Declares September 2024 Monthly Distribution
-
Gibson Energy Announces Renewal of Normal Course Issuer Bid
-
Tree Island Steel Announces Quarterly Dividend
-
DO Apparel Expands Digital Production of Custom Jerseys for Large Sports Brands with Kornit Digital
-
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
-
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024
-
Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
-
BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinom
-
Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer
-
InterDigital Announces Annual Recurring Revenue Target Of $1 Billion By 2030
-
CAPREIT Announces September 2024 Distribution
-
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
-
Presentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV Therapy
-
Odyssey Transfer and Trust Company Appoints Bill Collins as CRO to Accelerate Growth
-
Shirofune Showcases Industry-Leading Digital Advertising Automation at IAB Connected Commerce Summit 2024
-
Enphase Energy Launches IQ Battery 5P and IQ Energy Management Software in Belgium
-
BioVie Secures All Scientific Approvals Needed to Receive Additional $12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Long COVID
-
Aqua Security Launches VEX Hub Repository and Expands Trivy’s Scanning Capabilities
-
Theriva™ Biologics Awarded Manufacturing Funding from the Spanish Government’s National Knowledge Transfer Program
-
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
-
Provident Bank Announces $88,000 in Grants to Nine New Jersey Non-Profit Organizations
-
Canada's Only Single-Dose Cholera Vaccine Available Nationwide
-
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
-
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
-
SRx Health Insiders Purchase Shares of Better Choice in the Open Market
-
BOS’ Supply Chain Division Receives an Order in the amount of $900,000
-
PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide
-
Huntress Surpasses $100M ARR By Democratizing Cybersecurity for Small and Mid-Sized Enterprises
-
Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies
-
Monarch Private Capital and Invenergy Close Nearly $170 Million Tax Equity Financing for Samson Solar Energy Center II
-
Lotus Robotics Selected to Supply to a World-Class Japanese Tier-One Supplier
-
Coda Octopus Group Reports Fiscal Third Quarter 2024 Financial Results
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024
